Tabla de Contenido
Endocrine-Related : Cancer Vol. 16 año2009 No. 1
REVIEW • A novel role of Shc adaptor proteins in steroid hormone-regulated cancers • Syed Mahfuzul Alam, Mythilypriya .pág1–16 • Anaplastic thyroid cancer: molecular pathogenesis and emerging therapies .pág17–44 • Are neuroendocrine tumours a feature of tuberous sclerosis? A systematic review.pág45–58 RESEARCH • Analysis of the oestrogen response in an angiomyolipoma derived xenograft model .pág59–72 • Incomplete surgical resection of ductal carcinomas in situ results in activation of • ERBB2 in residual breast cancer cells.pág73–83 • Regression of progestin-accelerated 7,12-dimethylbenz[a]anthracene-induced mammary • tumors in Sprague–Dawley rats by p53 reactivation and induction of massive apoptosis: • a pilot study.pág85–98 • Molecular classification of spontaneous endometrial adenocarcinomas in BDII rats.pág99–111 • Autocrine stimulation of IGF1 in estrogeninduced growth of endometrial carcinoma cells: involvement of the mitogen-activated protein kinase pathway followed by up-regulation of cyclin D1 and cyclin E.pág113–122
• Expression and significance of androgen receptor coactivators in urothelial carcinoma of the bladder.pág123–137
• The single-macro domain protein LRP16 is an essential cofactor of androgen receptor.pág139–153 • Interleukin-6 stimulation of growth of prostate cancer in vitro and in vivo through activation of the androgen receptor.pág155–169 • Modification of multiple endocrine neoplasia 2A phenotype by cell membrane proximity of RET mutations in exon 10.pág171–177 • Gonadotropin-stimulated epidermal growth factor receptor expression in human ovarian surface epithelial cells: involvement of cyclic AMP-dependent exchange protein activated by cAMP pathway.pág179–188 • FOXO3a: a novel player in thyroid carcinogenesis?pág189–199 • Outcome predictors and impact of central node dissection and radiometabolic treatments in papillary thyroid cancers %2 cm.pág201–210
• Transcriptome analysis in mouse tumors induced by Ret-MEN2/FMTC mutations • reveals subtype-specific role in survival and interference with immune surveillance.pág 211–224 • Secretive and proliferative tumor profile helps to select the best imaging technique to identify postoperative persistent or relapsing medullary thyroid cancer.pág225–231 • Identification of tyrosine 806 as a molecular determinant of RET kinase sensitivity to • ZD6474.pág 233–241 • Sporadic hypercalcitoninemia: clinical and therapeutic consequences .pág243–253 • The clinical value of [18F]fluorodihydroxyphenylalanine positron emission • tomography in primary diagnosis, staging, and restaging of neuroendocrine tumors.pág255–265 • Homeodomain transcription factor NKX2.2 functions in immature cells to control • enteroendocrine differentiation and is expressed in gastrointestinal neuroendocrine tumors.pág267–279
• Metoclopramide stimulates catecholamine- and granin-derived peptide secretion from • pheochromocytoma cells through activation of serotonin type 4 (5-HT4) receptors.pág281–290 • Mediastinal paragangliomas: association with mutations in the succinate dehydrogenase genes and aggressive behavior.pág291–299
• Frequent mutations and amplifications of the PIK3CA gene in pituitary tumors.pág301–310 • Serum IGF-I, IGFBP-3, and matrix metalloproteinase-7 levels and acquired chemoresistance in advanced colorectal cancer.pág311–317
|